Global Injection Pen Market Trends, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global injection pen market in its upcoming report titled, “Global Injection Pen Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global injection pen market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global injection pen market report has been segmented on the basis of type, end user, and region.

Request Covid - 19 Impact

Injection pens are widely used in various therapeutic applications such diabetes, osteoporosis as it provides various advantages over the traditional vial-and-syringe method. For instance, insulin pen devices improve patient satisfaction and adherence. Furthermore, it is easy to use and provides accuracy in delivering small dose of insulin. In addition, injection pen is user friendly, the small & thin needle sizes reduce fear and pain and thus has greater social acceptability. Injection pen is widely used in diabetic patients.

Increasing incidence of chronic diseases such as diabetes and osteoporosis globally is expected to drive the global injection pen market over the forecast period. According to American Diabetes Association, in 2015, 30.3 million people in US had diabetes which is 9.4% of the population. In addition, increasing preference of injection pen over the traditional vial-and-syringe method due to the rising incidence of needle stick injuries is expected to fuel the global injection pen market over the forecast period. Increasing number of product approvals for injection pen by health authorities for treatment of various diseases is expected propel the growth of global injection pen market.

However, preference of other alternative drug delivery modes such insulin patches are major factors restraining the growth of global injection pen market over the forecast period.

North America market dominates the global injection pen market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the increasing number of approval and subsequent launch of new product, increasing number of cases for diabetes, and continuous development of advanced injection pens by manufacturers in the region. Europe accounts for second-largest revenue share contribution to the global injection pen market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. This is attributed owing to rapidly growing geriatric population, improving healthcare infrastructure, and increasing number of awareness programs in the region.

Global injection pen market segmentation, by product:

• Disposable Injection Pen
• Reusable Injection Pen

Global injection pen market segmentation, by therapeutic application:

• Diabetes
• Growth Hormone Therapy
• Osteoporosis
• Fertility
• Others

Global injection pen market segmentation, by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Novo Nordisk A/S
• Sanofi SA
• Eli Lilly and Company
• Merck & Company, Inc.
• Astrazeneca plc
• Hoffmann-La Roche AG
• Becton, Dickinson and Company
• Novartis AG
• Pfizer Inc.
• Ypsomed